Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1340-1346

  Drechsler, Christiane ^a,b   Grootendorst, Diana C ^a   Boeschoten, Elisabeth W ^c   Krediet, Raymond T ^d   Wanner, Christoph ^b   Dekker, Friedo W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Hans Mak Institute   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

body mass index; dialysis; epidemiology; mortality; parathyroid hormone

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; END STAGE LIVER DISEASE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; UNDERWEIGHT; VASCULAR DISEASE;

BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; PARATHYROID HORMONE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; WEIGHT LOSS;

EID: 79953894362     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq541     Document Type: Article

References (35)

1. De Boer I, Gorodetskaya I, Young B et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 2002; 13: 2762-2769 (Pubitemid 35216046)
2. Fajtova VT, Sayegh MH, Hickey N et al. Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 1995; 57: 329-335
3. Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38 (Pubitemid 44967731)
4. Martinez I, Saracho R, Montenegro J et al. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997; 29: 496-502 (Pubitemid 27155269)
5. Pitts TO, Piraino BH, Mitro R et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 1988; 67: 876-881
6. Noordzij M, Boeschoten EW, Bos WJ et al. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant 2007; 22: 2944-2949 (Pubitemid 350093436)
7. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218 (Pubitemid 39031360)
8. Melamed ML, Eustace JA, Plantinga L et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 2006; 70: 351-357 (Pubitemid 44086585)
9. Tentori F, Blayney MJ, Albert JM et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2008; 52: 519-530
10. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187 (Pubitemid 41623345)
11. Coen G, Ballanti P, Bonucci E et al. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 2294-2302 (Pubitemid 28416556)
12. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure-an evolving disorder. Kidney Int 1993; 43: 436-442 (Pubitemid 23162839)
13. Avram MM, Sreedhara R, Avram DK et al. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia. Am J Kidney Dis 1996; 28: 924-930 (Pubitemid 26412091)
14. Avram MM, Mittman N, Myint MM et al. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis 2001; 38: 1351-1357 (Pubitemid 34193126)
15. Guh JY, Chen HC, Chuang HY et al. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis 2002; 39: 1245-1254
16. Bell NH, Epstein S, Greene A et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-373 (Pubitemid 15243466)
17. Bolland MJ, Grey AB, Gamble GD et al. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 2005; 90: 1525-1530 (Pubitemid 40464014)
18. Snijder MB, van Dam RM, Visser M et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90: 4119-4123 (Pubitemid 41058184)
19. Kovesdy CP, Ahmadzadeh S, Anderson JE et al. Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1024-1029
20. Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398 (Pubitemid 351186278)
21. De Mutsert R, Snijder MB, van der Sman-de Beer F et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974 (Pubitemid 46434514)
22. Avram MM. Lower parathyroid hormone and creatinine in diabetic uremia. Contrib Nephrol 1980; 20: 4-8
23. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol 2004; 151: 167-172 (Pubitemid 39207010)
24. Parikh SJ, Edelman M, Uwaifo GI et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196-1199 (Pubitemid 38368412)
25. Wortsman J, Matsuoka LY, Chen TC et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693 (Pubitemid 30667088)
26. Liel Y, Ulmer E, Shary J et al. Low circulating vitamin D in obesity. Calcif Tissue Int 1988; 43: 199-201
27. Olmos JM, Vazquez LA, Amado JA et al. Mineral metabolism in obese patients following vertical banded gastroplasty. Obes Surg 2008; 18: 197-203
28. De Mutsert R, Grootendorst DC, Boeschoten EWet al. Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients. Am J Clin Nutr 2009; 89: 787-793
29. Dukkipati R, Kovesdy CP, Colman S et al. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. J Ren Nutr 2010; 20: 243-254
30. Drechsler C, Krane V, Grootendorst DC et al. The association between parathyroid hormone and mortality in dialysis patients is modified by wasting. Nephrol Dial Transplant 2009; 24: 3151-3157
31. Andress DL. Adynamic bone in patients with chronic kidney disease. Kidney Int 2008; 73: 1345-1354 (Pubitemid 351770492)
32. Sanchez-Gonzalez MC, Lopez-Barea F, Bajo MA et al. Serum albumin levels, an additional factor implicated in hyperparathyroidism outcome in peritoneal dialysis: a prospective study with paired bone biopsies. Adv Perit Dial 2006; 22: 198-202
33. Carlstedt E, Ridefelt P, Lind L et al. Interleukin-6 induced suppression of bovine parathyroid hormone secretion. Biosci Rep 1999; 19: 35-42 (Pubitemid 29248703)
34. Nielsen PK, Rasmussen AK, Butters R et al. Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem Biophys Res Commun 1997; 238: 880-885 (Pubitemid 27472670)
35. Elefteriou F, Takeda S, Ebihara K et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA 2004; 101: 3258-3263 (Pubitemid 38327768)